Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease-Reference-Cited by-同舟云学术

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease

Published:2021-05-04 Issue:1 Volume:90 Page:52-61
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Rosebraugh Matthew¹^ORCID,Voight Eric A.²,Moussa Ehab M.³,Jameel Feroz³,Lou Xiaochun³,Zhang Geoff G. Z.³,Mayer Peter T.⁴,Stolarik Deanne⁵,Carr Robert A.⁵,Enright Brian P.⁶,Liu Wei¹,Facheris Maurizio F.⁷,Kym Philip R.²

Affiliation:

1. Clinical Pharmacology and Pharmacometrics AbbVie Inc. North Chicago IL

2. Discovery Centralized Medicinal Chemistry AbbVie Inc. North Chicago IL

3. Drug Product Development AbbVie Inc. North Chicago IL

4. Clinical Drug Supply Management AbbVie Inc. North Chicago IL

5. Drug Metabolism Pharmacokinetics and Bioanalysis AbbVie Inc. North Chicago IL

6. Preclinical Safety AbbVie Inc. North Chicago IL

7. Neuroscience Development AbbVie Inc. North Chicago IL

Funder

AbbVie

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26073

Reference23 articles.

1. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Parkinson's disease

3. Advances in Parkinson’s Disease: 200 Years Later

4. An Essay on the Shaking Palsy

5. Substantia Nigra and Parkinson's Disease: A Brief History of Their Long and Intimate Relationship

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s Disease;International Encyclopedia of Public Health;2025

2. Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s Disease (aPD): demonstration of savings from a societal perspective in the UK;Journal of Medical Economics;2024-09-10

3. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways;Cell Communication and Signaling;2024-08-30

4. Subcutaneous foslevodopa in akinetic crisis. A case report from the neurological intensive care unit;Frontiers in Medicine;2024-08-26

5. Natural Product-Inspired Dopamine Receptor Ligands;Journal of Medicinal Chemistry;2024-07-22